The Efficiency of Acupuncture Combined Intradermal Sterile Water Application in Acute Renal Colic
Launched by THE THIRD AFFILIATED HOSPITAL OF BEIJING UNIVERSITY OF CHINESE MEDICINE · Jan 27, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new way to relieve pain from acute renal colic, which is severe pain caused by kidney stones. The study compares two treatments: one group of participants will receive a medication called phloroglucinol through an injection, while the other group will receive acupuncture along with a special application of sterile water under the skin. Researchers want to see which treatment works better for pain relief and how well patients tolerate each method.
To participate in this trial, you need to be an adult over 18 years old and have uncomplicated acute renal colic, which means you have sudden pain in your side or lower abdomen without other serious symptoms like fever or decreased urine output. If you join, you'll be randomly assigned to one of the two treatment groups, and your pain will be measured at various points after treatment. It's important to note that some people, such as those with certain medical conditions or who are pregnant, won't be eligible for this study. All participants will need to provide informed consent before starting, ensuring they understand the study and agree to participate.
Gender
ALL
Eligibility criteria
- • Inclusion criteria:We included all consecutive patients aged \>18 years and presenting to our medical center with uncomplicated acute renal colic. Renal colic was considered if the patient description of pain included sudden onset of symptoms; unilateral flank or lower abdomen pain; irradiation to the back, side, or groin region; urination problems, including urinating difficultly and/or an abnormally dark or red urine; and the absence of other obvious conditions explaining patient symptoms.
- • Exclusion criteria:We excluded patients with complicated acute renal colic, defined by the presence of bilateral pain, fever, and/or decreased urine output (\<500 mL per day). Patients presenting with posttraumatic pain, those taking anticoagulant medications or with coagulation problems, those with skin afflictions (infections, hematoma, dermatosis) that would impair the use of certain acupuncture points, those unable to assess the degree of pain using the VAS, those who had received analgesics in the 6 hours prior to enrollment, those refusing or unable to give written consent, and pregnant women were also excluded from this study. All participants read and signed the informed consent form of the study, which was approved by the ethics committee of the Third Affiliated Hospital of Beijing University of Chinese Medicine.
About The Third Affiliated Hospital Of Beijing University Of Chinese Medicine
The Third Affiliated Hospital of Beijing University of Chinese Medicine is a leading institution in integrative healthcare and clinical research, dedicated to advancing medical knowledge and patient care through innovative clinical trials. With a strong emphasis on traditional Chinese medicine combined with modern medical practices, the hospital fosters a multidisciplinary approach to research, aiming to improve therapeutic outcomes and enhance the quality of life for patients. Committed to ethical standards and scientific rigor, the hospital collaborates with a network of healthcare professionals and researchers to explore new treatment modalities and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported